| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Ticho Barry is a Chief Medical Officer at Stoke Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $11.37 | $113,653.00 | -80.1% | +26.1% | -14.6% | |
| Apr 1, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 9,426 | $13.23 | $124,684.30 | -79.1% | +2.8% | -53.8% | |
| Mar 19, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 4,116 | $6.10 | $25,101.84 | -26.4% | +169.0% | +42.4% | |
| Mar 1, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 10,000 | $7.75 | $77,469.00 | -80.1% | +80.6% | +2.9% | |
| Feb 1, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 10,000 | $4.80 | $47,991.00 | -58.9% | +136.4% | +134.8% | |
| Jan 2, 2024 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 10,000 | $5.74 | $57,352.00 | -37.1% | +130.2% | +92.3% | |
| Jul 3, 2023 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 15,000 | $10.60 | $158,973.00 | -36.7% | -65.4% | +20.4% | |
| Jun 1, 2023 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 15,000 | $11.13 | $166,963.50 | -26.8% | -49.1% | +29.5% | |
| May 4, 2023 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 653 | $10.00 | $6,530.00 | -1.2% | -41.6% | +12.1% | |
| May 3, 2023 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 55,177 | $10.06 | $555,267.07 | -19.7% | -32.8% | +23.2% |